Techniques in Vascular & Interventional Radiology
Volume 10, Issue 4 , Pages 261-269 , December 2007

Drug-Eluting Particles for Interventional Pharmacology

  • Eleni Liapi, MD

      Affiliations

    • The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cardiovascular and Interventional Radiology, The Johns Hopkins Hospital, Baltimore, MD, USA.
    • ,
  • Kwang-Hun Lee, MD

      Affiliations

    • The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cardiovascular and Interventional Radiology, The Johns Hopkins Hospital, Baltimore, MD, USA.
    • Division of Interventional Radiology, Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
    • ,
  • Christos C. Georgiades, MD, PhD

      Affiliations

    • The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cardiovascular and Interventional Radiology, The Johns Hopkins Hospital, Baltimore, MD, USA.
    • ,
  • Kelvin Hong, MD

      Affiliations

    • The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cardiovascular and Interventional Radiology, The Johns Hopkins Hospital, Baltimore, MD, USA.
    • ,
  • Jean-Francois H. Geschwind, MD

      Affiliations

    • The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cardiovascular and Interventional Radiology, The Johns Hopkins Hospital, Baltimore, MD, USA.
    • Corresponding Author InformationAddress reprint requests to: Jean-Francois H. Geschwind, MD, Interventional Radiology Research, The Johns Hopkins Hospital, Baltimore, MD 21287.

References 

  1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156
  2. Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol. 2007;25:978–986
  3. Okuda K. Hepatocellular carcinoma. J Hepatol. 2000;32(suppl):225–237
  4. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
  5. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–1739
  6. Yamada R, Nakatsuka H, Nakamura K, et al. Hepatic artery embolization in 32 patients with unresectable hepatoma. Osaka City Med J. 1980;26:81–96
  7. Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397–401
  8. Takahashi T. Development and clinical application of drug delivery systems for cancer treatment. Int J Clin Oncol. 2002;7:206–218
  9. Hong K, Khwaja A, Liapi E, et al. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006;12:2563–2567
  10. Lewis A, Gonzalez M, Leppard S, et al. Doxorubicin eluting beads (1. Effects of drug loading on bead characteristics and drug distribution). J Mater Sci Mater Med. 2007;18:1691–1699
  11. Lewis AL, Gonzalez MV, Lloyd AW, et al. DC Bead: In vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol. 2006;17:335–342
  12. Lewis AL, Taylor RR, Hall B, et al. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol. 2006;17:1335–1343
  13. Taylor RR, Tang Y, Gonzalez MV, et al. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci. 2007;30:7–14
  14. Varela M, Real MI, Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46:474–481
  15. Haaga JR, Exner AA, Wang Y, et al. Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits. Radiology. 2005;237:911–918
  16. Weinberg BD, Blanco E, Gao J. Polymer implants for intratumoral drug delivery and cancer therapy. J Pharm Sci. 2007;97(5):1681–1702
  17. Qian J, Truebenbach J, Graepler F, et al. Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. World J Gastroenterol. 2003;9:94–98
  18. Constantin M, Fundueanu G, Bortolotti F, et al. Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs. Int J Pharm. 2004;285:87–96
  19. Vallee JN, Lo D, Guillevin R, et al. In vitro study of the compatibility of tris-acryl gelatin microspheres with various chemotherapeutic agents. J Vasc Interv Radiol. 2003;14:621–628
  20. Fujiwara K, Hayakawa K, Nagata Y, et al. Experimental embolization of rabbit renal arteries to compare the effects of poly l-lactic acid microspheres with and without epirubicin release against intraarterial injection of epirubicin. Cardiovasc Intervent Radiol. 2000;23:218–223
  21. de Luis E, Bilbao J, de Ciércoles J, Martínez-Cuesta A, et al. In vivo evaluation of a new embolic spherical particle (HepaSphere) in a kidney animal model. Cardiovasc Intervent Radiol. 2008;31(2):367–376
  22. Gonzalez M, Tang Y, Phillips G, et al. Doxorubicin eluting beads (2. Methods for evaluating drug elution and in-vitro:in-vivo correlation). J Mater Sci Mater Med. 2008;19(2):767–775
  23. Maeda NOK, Mikami K, Higashihara H, et al. In vitro characterization of cisplatin-loaded super-absorbent polymer microspheres designed for chemoembolization. J Vasc Interv Radiol. 2007;18:S163–S189
  24. Geschwind JF, Khwaja A, Hong K. New intraarterial drug delivery system: pharmacokinetics and tumor response in an animal model of liver cancer 2005 (ASCO Annual Meeting, 2005. Orlando, Florida). 2005;
  25. Del Poggio P, Maddeo A, Zabbialini G. Chemoembolization of hepatocellular carcinoma with drug eluting beads. J Hepatol. 2007;47:157–158
  26. Poon RT, Tso WK, Pang RW, et al. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol. 2007;5:1100–1108
  27. Kamel IR, Reyes D, Wahlin T, Georgiades C, Hong K, et al. Pilot study with intraarterial doxorubicin-eluting icrospheres (GelSpheres) in patients with unresectable hepatocellular carcinoma: experience in the US. Am J Roentgenol. 2007;188(suppl 5):A56–A59
  28. Geschwind JF. Study of chemoembolization with GelSpheres beads mixed with doxorubicin hydrochloride in atients with unresectable hepatocellular carcinoma. National Cancer Institute Clinical Trials Database 2006;
  29. Reyes D, Geschwind J-FH, Wahlin T, et al. Intraarterial doxorubicin-eluting microspheres for patients with unresectable hepatocellular carcinoma: a pilot study (CIRSE 2007). Athens, Greece: European Society of Cardiovascular Interventional Radiology; 2007;
  30. Massa Saluzzo C, Vignali C, Nicolini A, et al. TACE with HepaSphere microspheres loaded with chemotherapeutic agent: early experience in Italy of a multi-centre study (WCIO 2007). Washington, DC 2007;
  31. Vogl T, Lencioni R. The future of interventional oncology (CIRSE 2006). Rome, Italy 2006;
  32. Coenegrachts K, De Baère T, Abdel RM, et al. Transarterial chemoembolization (TACE) of neuroendocrine hepatic metastases using drug eluting beads. Radiological Society of North America 91st Annual Scientific Meeting, 2005. Chicago, IL 2005;
  33. Lu DSK, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. 2005;234:954–960
  34. Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. 2006;16:661–669
  35. Tang Y, Taylor RR, Gonzalez MV, et al. Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases. J Controlled Release. 2006;116:e55-e6
  36. Aliberti C, Tilli M, Benea G, et al. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res. 2006;26:3793–3795
  37. Kim JS, Kwak BK, Shim HJ, et al. Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma. J Microencapsul. 2007;24:408–419
  38. Liu X, Heng WS, Paul , Li Q, et al. Novel polymeric microspheres containing norcantharidin for chemoembolization. J Controlled Release. 2006;116:35–41
  39. Misirli Y, Ouml ZT, Ouml RK, et al. Preparation and characterization of mitomycin-C loaded chitosan-coated alginate microspheres for chemoembolization. J Microencapsulation. 2005;22:167–178

PII: S1089-2516(08)00004-8

doi: 10.1053/j.tvir.2008.03.003

Techniques in Vascular & Interventional Radiology
Volume 10, Issue 4 , Pages 261-269 , December 2007

Article Tools

* Image Usage & Resolution